Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab Re-challenge in mCRC
NCT04224415Phase 2Completed
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in metastatic colorectal cancer (mCRC). Started Jan 2020; status: completed.
02
Drugs
KL-140
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT04224415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224415.